MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-11531

  1. 2,479 Posts.
    lightbulb Created with Sketch. 274
    the MABs reduce hospitalisation and death by 70%.

    and are 80% effective as a prophylactic.

    the only "problem" with them is their cost.

    they work. independent of any other drug.

    pls show me MSB ARDs success figures. i mean, without the support of another drug doing all the heavy lifting.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.